Metabolic Syndrome Observation on a Regional Basis

NCT00933010 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1600

Last updated 2010-10-13

No results posted yet for this study

Summary

The aim of the study is to assess the prevalence of Metabolic Syndrome in Italy on a regional basis, defined according to NCEP/ATPIII Guidelines criteria.

Conditions

  • Metabolic Syndrome

Sponsors & Collaborators

Principal Investigators

  • Mario Mangrella · AstraZeneca S.p.A., R&D

  • Raffaele Sabia · AstraZeneca S.p.A., R&D

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00933010 on ClinicalTrials.gov